3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
53
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Burkitt Lymphoma
10
Leukemia
9
Myelodysplastic Syndromes
7
Leukemia, Biphenotypic, Acute
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Down Syndrome
3
Sarcoma, Myeloid
2
Lymphoma
2
Leukemia, Monocytic, Acute
2
Hematologic Neoplasms
2
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Philadelphia Chromosome
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, T-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Basophilic, Acute
1
Acute Myeloid Leukemia With KMT2A Rearrangement
1
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Daunorubicin
×
1 year
×
Clear all
No trials found.